Circadian variations of bone marrow engraftability

被引:32
作者
D'Hondt, L
McAuliffe, C
Damon, J
Reilly, J
Carlson, J
Dooner, M
Colvin, G
Lambert, JF
Hsieh, CC
Habibian, H
Stencel, K
Quesenberry, PJ
机构
[1] Roger Williams Canc Med Ctr, Ctr Stem Cell Biol, Dept Res, Providence, RI 02908 USA
[2] Roger Williams Canc Med Ctr, Decof Canc Ctr, Providence, RI 02908 USA
[3] Ctr Hosp Notre Dame & Reine Fabiola, Charleroi, Belgium
[4] Univ Massachusetts, Ctr Canc, Worcester, MA 01605 USA
关键词
D O I
10.1002/jcp.20032
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Circadian rhythms exist for hematopoiesis, but little is known about circadian variation of bone marrow engraftability and host "acceptability". Using a B6.SJL to C57BL/6J congenic transplant model, we chose 3-times with light on: Hours After Light Onset (HALO) 4, 8, and 12 and 3-times with light off: HALO 16, 20, and 24. The mice were conditioned on a 12-h light/dark cycles. Recipient mice (100 cGy) received 40 million cells. We demonstrated a significant variation of bone marrow engraftability into bone marrow, spleen, and thymus when donor animals were subjected to changes in their light/dark cycles. Two statistically significant nadirs in all three organs were observed at HALO 8 and 24 in experiments carried out in July, while an identical set of experiments in February analyzing engraftment in marrow and spleen showed nadirs at HALO 8, but not at HALO 24. Marrow progenitors from the July experiments showed nadirs at HALO 12 and 24. The percentage of progenitors in S phase peaked at HALO 8 and 24. Interestingly, there were no changes in the ability of host to accept grafts with changes in the light/dark cycles of host animals. Circadian variations of bone marrow engraftability are important and should be considered in bone marrow transplant strategies. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:63 / 70
页数:8
相关论文
共 25 条
[1]  
AARDAL NP, 1983, EXP HEMATOL, V11, P792
[2]  
Abrahamsen JF, 1998, EUR J HAEMATOL, V60, P7
[3]   Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle status [J].
Becker, PS ;
Nilsson, SK ;
Li, ZF ;
Berrios, VM ;
Dooner, MS ;
Cooper, CL ;
Hsieh, CC ;
Quesenberry, PJ .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (03) :533-541
[4]   The molecular basis for the cytokine-induced defect in homing and engraftment of hematopoietic stem cells [J].
Berrios, VM ;
Dooner, GJ ;
Nowakowski, G ;
Frimberger, A ;
Valinski, H ;
Quesenberry, PJ ;
Becker, PS .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (11) :1326-1335
[5]   Homing of purified murine lymphohematopoietic stem cells: A cytokine-induced defect [J].
Cerny, J ;
Dooner, M ;
McAuliffe, C ;
Habibian, H ;
Stencil, K ;
Berrios, V ;
Reilly, J ;
Carlson, J ;
Cerny, AM ;
d'Hondt, L ;
Benoit, B ;
Lambert, JF ;
Colvin, G ;
Nilsson, S ;
Becker, P ;
Quesenberry, P .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (06) :913-922
[6]   Solution- and solid-phase syntheses of substituted guanidinocarboxylic acids [J].
Chen, J ;
Pattarawarapan, M ;
Zhang, AJ ;
Burgess, K .
JOURNAL OF COMBINATORIAL CHEMISTRY, 2000, 2 (03) :276-281
[7]   Evidence for melatonin synthesis in mouse and human bone marrow cells [J].
Conti, A ;
Conconi, S ;
Hertens, E ;
Skwarlo-Sonta, K ;
Markowska, M ;
Maestroni, GJM .
JOURNAL OF PINEAL RESEARCH, 2000, 28 (04) :193-202
[8]   Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts [J].
D'Hondt, L ;
Carlson, J ;
Benoit, B ;
Reilly, J ;
Grimaldi, C ;
Wuu, J ;
Lambert, JF ;
Dooner, MS ;
Quesenberry, PJ .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 74 (01) :79-85
[9]  
GOLDECK H, 1948, ARZTL FORSCH, V2, P22
[10]   The fluctuating phenotype of the lymphohematopoietic stem cell with cell cycle transit [J].
Habibian, HK ;
Peters, SO ;
Hsieh, CC ;
Wuu, J ;
Vergilis, K ;
Grimaldi, CI ;
Reilly, J ;
Carlson, JE ;
Frimberger, AE ;
Stewart, FM ;
Quesenberry, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) :393-398